190 related articles for article (PubMed ID: 21995575)
21. [Antitumor immunity and cellular cancer therapies].
Catros-Quemener V; Bouet F; Genetet N
Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
[TBL] [Abstract][Full Text] [Related]
22. Interaction between tumor and immune system: the role of tumor cell biology.
Berezhnaya NM
Exp Oncol; 2010 Sep; 32(3):159-66. PubMed ID: 21403611
[TBL] [Abstract][Full Text] [Related]
23. Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy.
Fisher DT; Chen Q; Appenheimer MM; Skitzki J; Wang WC; Odunsi K; Evans SS
Immunol Invest; 2006; 35(3-4):251-77. PubMed ID: 16916754
[TBL] [Abstract][Full Text] [Related]
24. Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment.
Menon H; Ramapriyan R; Cushman TR; Verma V; Kim HH; Schoenhals JE; Atalar C; Selek U; Chun SG; Chang JY; Barsoumian HB; Nguyen QN; Altan M; Cortez MA; Hahn SM; Welsh JW
Front Immunol; 2019; 10():193. PubMed ID: 30828330
[TBL] [Abstract][Full Text] [Related]
25. Radiation-Induced Transformation of Immunoregulatory Networks in the Tumor Stroma.
Martinez-Zubiaurre I; Chalmers AJ; Hellevik T
Front Immunol; 2018; 9():1679. PubMed ID: 30105016
[TBL] [Abstract][Full Text] [Related]
26. Hyaluronan in human malignancies.
Sironen RK; Tammi M; Tammi R; Auvinen PK; Anttila M; Kosma VM
Exp Cell Res; 2011 Feb; 317(4):383-91. PubMed ID: 21134368
[TBL] [Abstract][Full Text] [Related]
27. Classification and biology of tumour associated stromal cells.
Raffaghello L; Dazzi F
Immunol Lett; 2015 Dec; 168(2):175-82. PubMed ID: 26145459
[TBL] [Abstract][Full Text] [Related]
28. New insights into the role of extracellular matrix during tumor onset and progression.
Pupa SM; Ménard S; Forti S; Tagliabue E
J Cell Physiol; 2002 Sep; 192(3):259-67. PubMed ID: 12124771
[TBL] [Abstract][Full Text] [Related]
29. Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model.
Martin ML; Wall EM; Sandwith E; Girardin A; Milne K; Watson PH; Nelson BH
Breast Cancer Res Treat; 2010 Jun; 121(3):753-63. PubMed ID: 19789976
[TBL] [Abstract][Full Text] [Related]
30. The tumor microenvironment: part 1.
Leibovici J; Itzhaki O; Huszar M; Sinai J
Immunotherapy; 2011 Nov; 3(11):1367-84. PubMed ID: 22053887
[TBL] [Abstract][Full Text] [Related]
31. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
32. Journey through the thymus: stromal guides for T-cell development and selection.
Takahama Y
Nat Rev Immunol; 2006 Feb; 6(2):127-35. PubMed ID: 16491137
[TBL] [Abstract][Full Text] [Related]
33. Equilibrium between host and cancer caused by effector T cells killing tumor stroma.
Zhang B; Zhang Y; Bowerman NA; Schietinger A; Fu YX; Kranz DM; Rowley DA; Schreiber H
Cancer Res; 2008 Mar; 68(5):1563-71. PubMed ID: 18316622
[TBL] [Abstract][Full Text] [Related]
34. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].
Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E
Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756
[TBL] [Abstract][Full Text] [Related]
35. The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts.
Tzukerman M; Rosenberg T; Reiter I; Ben-Eliezer S; Denkberg G; Coleman R; Reiter Y; Skorecki K
Cancer Res; 2006 Apr; 66(7):3792-801. PubMed ID: 16585206
[TBL] [Abstract][Full Text] [Related]
36. Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application.
Gomes AQ; Martins DS; Silva-Santos B
Cancer Res; 2010 Dec; 70(24):10024-7. PubMed ID: 21159627
[TBL] [Abstract][Full Text] [Related]
37. Inflammation and immunity in the tumor environment.
Maletzki C; Emmrich J
Dig Dis; 2010; 28(4-5):574-8. PubMed ID: 21088404
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cells.
Lankester AC; Ball LM; Lang P; Handgretinger R
Pediatr Clin North Am; 2010 Feb; 57(1):97-121. PubMed ID: 20307714
[TBL] [Abstract][Full Text] [Related]
40. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
